10x Genomics ROE 2018-2025 | TXG

Current and historical return on equity (ROE) values for 10x Genomics (TXG) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
10x Genomics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.16B $0.71B -21.93%
2024-12-31 $-0.18B $0.71B -25.45%
2024-09-30 $-0.18B $0.72B -25.18%
2024-06-30 $-0.24B $0.72B -32.78%
2024-03-31 $-0.26B $0.72B -35.22%
2023-12-31 $-0.26B $0.74B -33.11%
2023-09-30 $-0.22B $0.75B -28.35%
2023-06-30 $-0.17B $0.79B -21.66%
2023-03-31 $-0.17B $0.80B -21.97%
2022-12-31 $-0.17B $0.81B -20.80%
2022-09-30 $-0.17B $0.78B -20.85%
2022-06-30 $-0.14B $0.78B -17.58%
2022-03-31 $-0.09B $0.81B -10.97%
2021-12-31 $-0.06B $0.82B -7.35%
2021-09-30 $-0.46B $0.80B -59.30%
2021-06-30 $-0.51B $0.79B -65.14%
2021-03-31 $-0.53B $0.75B -78.91%
2020-12-31 $-0.54B $0.74B -91.88%
2020-09-30 $-0.13B $0.83B -26.21%
2020-06-30 $-0.08B $0.39B -25.57%
2020-03-31 $-0.05B $0.41B -23.64%
2019-12-31 $-0.03B $0.42B -30.48%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.100B $0.611B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.988B 53.85
Hims & Hers Health (HIMS) United States $13.954B 144.98
Tempus AI (TEM) United States $10.977B 0.00
IRhythm Technologies (IRTC) United States $4.526B 0.00
Inspire Medical Systems (INSP) United States $4.418B 69.02
Privia Health (PRVA) United States $3.048B 208.33
Enovis (ENOV) United States $2.027B 11.30
Clover Health Investments (CLOV) United States $1.832B 0.00
Schrodinger (SDGR) United States $1.721B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.305B 23.02
Azenta (AZTA) United States $1.242B 57.70
Fulgent Genetics (FLGT) United States $0.646B 0.00
Butterfly Network (BFLY) United States $0.574B 0.00
Talkspace (TALK) United States $0.504B 150.50
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.452B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.376B 834.00
Health Catalyst (HCAT) United States $0.271B 0.00
Nyxoah SA (NYXH) Belgium $0.231B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.134B 0.00
American Well (AMWL) United States $0.114B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.088B 3.34
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.068B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) Netherlands $0.041B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00